Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
1. INTRINSIC VALUE
2. FUNDAMENTAL
ANALYSIS
Price Chart SGMO
FINANCIALS
Balance Sheet
Sangamo Therapeutics, Inc.
| Current Assets | 94.3 M |
| Cash & Short-Term Investments | 81 M |
| Receivables | 1.33 M |
| Other Current Assets | 12 M |
| Non-Current Assets | 71 M |
| Long-Term Investments | 0 |
| PP&E | 52.9 M |
| Other Non-Current Assets | 18.1 M |
| Current Liabilities | 47.7 M |
| Accounts Payable | 15.3 M |
| Short-Term Debt | 4.59 M |
| Other Current Liabilities | 27.9 M |
| Non-Current Liabilities | 34.7 M |
| Long-Term Debt | 33.5 M |
| Other Non-Current Liabilities | 1.19 M |
EFFICIENCY
Earnings Waterfall
Sangamo Therapeutics, Inc.
| Revenue | 176 M |
| Cost Of Revenue | 222 M |
| Gross Profit | -45.3 M |
| Operating Expenses | 450 M |
| Operating Income | -274 M |
| Other Expenses | -16.2 M |
| Net Income | -258 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sangamo Therapeutics, Inc.
| Net Income | -258 M |
| Depreciation & Amortization | 22.2 M |
| Capital Expenditures | -21.2 M |
| Stock-Based Compensation | 27.4 M |
| Change in Working Capital | -164 M |
| Others | -19 M |
| Free Cash Flow | -246 M |
Wall Street Analysts Price Targets
Sangamo Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SGMO of $5.67 , with forecasts ranging from
a
low of
$2 to a high of $19 .
SGMO Lowest Price Target
Wall Street Target
2 USD
83.49%
SGMO Average Price Target
Wall Street Target
5.67 USD
419.88%
SGMO Highest Price Target
Wall Street Target
19 USD
1643.12%
4. DIVIDEND
ANALYSIS
SGMO does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Sangamo Therapeutics, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
1 year ago
Sep 26, 2023
|
Sell 3 M
USD
|
BIOGEN INC.
10 percent owner
|
- 6000000
|
0.5 USD |
|
2 years ago
Aug 29, 2022
|
Sell 2.13 M
USD
|
BIOGEN INC.
10 percent owner
|
- 400000
|
5.3268 USD |
|
2 years ago
Aug 29, 2022
|
Sell 2.13 M
USD
|
Biogen MA Inc.
director:
|
- 400000
|
5.3268 USD |
|
2 years ago
Aug 30, 2022
|
Sell 527 K
USD
|
BIOGEN INC.
10 percent owner
|
- 100000
|
5.2652 USD |
|
2 years ago
Aug 29, 2022
|
Sell 527 K
USD
|
Biogen MA Inc.
director:
|
- 100000
|
5.2652 USD |
|
2 years ago
Jun 03, 2022
|
Bought
25 K USD
|
Markels John
director:
|
+ 6784
|
3.6894 USD |
|
2 years ago
Jun 01, 2022
|
Bought
18 K USD
|
PARKER H STEWART
director:
|
+ 5000
|
3.5992 USD |
|
3 years ago
Dec 28, 2021
|
Sell 23.5 K
USD
|
BIOGEN INC.
10 percent owner
|
- 2764
|
8.5101 USD |
|
3 years ago
Dec 23, 2021
|
Sell 695 K
USD
|
BIOGEN INC.
10 percent owner
|
- 81187
|
8.5547 USD |
|
3 years ago
Dec 27, 2021
|
Sell 5.14 K
USD
|
BIOGEN INC.
10 percent owner
|
- 600
|
8.56 USD |
|
3 years ago
Dec 09, 2021
|
Sell 203 K
USD
|
BIOGEN INC.
10 percent owner
|
- 23660
|
8.5605 USD |
|
3 years ago
Dec 07, 2021
|
Sell 444 K
USD
|
BIOGEN INC.
10 percent owner
|
- 52178
|
8.5177 USD |
|
3 years ago
Dec 08, 2021
|
Sell 655 K
USD
|
BIOGEN INC.
10 percent owner
|
- 75814
|
8.6373 USD |
|
3 years ago
Dec 01, 2021
|
Sell 6.22 K
USD
|
BIOGEN INC.
10 percent owner
|
- 730
|
8.5249 USD |
|
3 years ago
Dec 02, 2021
|
Sell 15.9 K
USD
|
BIOGEN INC.
10 percent owner
|
- 1874
|
8.5074 USD |
|
3 years ago
Nov 26, 2021
|
Sell 248 K
USD
|
BIOGEN INC.
10 percent owner
|
- 28884
|
8.6011 USD |
|
3 years ago
Mar 23, 2021
|
Sell 157 K
USD
|
LOEB GARY
EVP, General Counsel & Sec.
|
- 11981
|
13.1032 USD |
|
3 years ago
Mar 23, 2021
|
Sell 65.9 K
USD
|
LOEB GARY
EVP, General Counsel & Sec.
|
- 5000
|
13.1801 USD |
|
3 years ago
Mar 23, 2021
|
Sell 7.15 K
USD
|
LOEB GARY
EVP, General Counsel & Sec.
|
- 543
|
13.1713 USD |
|
4 years ago
Dec 31, 2020
|
Sell 41.2 K
USD
|
Ramelmeier Rolf Andrew
EVP, Technical Operations
|
- 2464
|
16.74 USD |
|
4 years ago
Dec 24, 2020
|
Sell 60.4 K
USD
|
Ramelmeier Rolf Andrew
EVP, Technical Operations
|
- 3331
|
18.13 USD |
|
4 years ago
Dec 17, 2020
|
Sell 133 K
USD
|
Ramasastry Saira
Director
|
- 10000
|
13.2747 USD |
|
4 years ago
Mar 19, 2020
|
Sell 210 K
USD
|
DILLY STEPHEN GEORGE
Director
|
- 35000
|
6 USD |
|
4 years ago
Mar 18, 2020
|
Bought
15.6 K USD
|
PARKER H STEWART
Director
|
+ 3000
|
5.195 USD |
|
4 years ago
Mar 17, 2020
|
Bought
25 K USD
|
Zakrzewski Joseph S
Director
|
+ 5000
|
4.99 USD |
|
4 years ago
Mar 16, 2020
|
Sell 90.3 K
USD
|
DILLY STEPHEN GEORGE
Director
|
- 15000
|
6.0174 USD |
|
4 years ago
Mar 13, 2020
|
Bought
28.4 K USD
|
Zakrzewski Joseph S
Director
|
+ 5000
|
5.67 USD |
|
4 years ago
Mar 12, 2020
|
Bought
94.6 K USD
|
Zakrzewski Joseph S
Director
|
+ 15000
|
6.31 USD |
|
5 years ago
May 15, 2019
|
Sell 50 K
USD
|
Yi Kathy
EVP & Chief Financial Officer
|
- 5000
|
10 USD |
|
5 years ago
Apr 15, 2019
|
Sell 60.6 K
USD
|
Yi Kathy
EVP & Chief Financial Officer
|
- 5000
|
12.11 USD |
|
5 years ago
Mar 15, 2019
|
Sell 50 K
USD
|
Yi Kathy
EVP & Chief Financial Officer
|
- 5000
|
10 USD |
|
5 years ago
Mar 01, 2019
|
Sell 50 K
USD
|
Yi Kathy
EVP & Chief Financial Officer
|
- 5000
|
10 USD |
|
6 years ago
Jan 15, 2019
|
Sell 55.2 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
11.04 USD |
|
6 years ago
Jan 07, 2019
|
Sell 61.6 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
12.3261 USD |
|
6 years ago
Dec 17, 2018
|
Sell 57.2 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
11.44 USD |
|
6 years ago
Dec 06, 2018
|
Sell 57.4 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
11.4866 USD |
|
6 years ago
Nov 15, 2018
|
Sell 50 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
10 USD |
|
6 years ago
Nov 14, 2018
|
Bought
18 K USD
|
PARKER H STEWART
Director
|
+ 2000
|
9.0008 USD |
|
6 years ago
Nov 06, 2018
|
Sell 68.6 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
13.73 USD |
|
6 years ago
Oct 15, 2018
|
Sell 69.8 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
13.97 USD |
|
6 years ago
Oct 08, 2018
|
Sell 72.8 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
14.5547 USD |
|
6 years ago
Sep 17, 2018
|
Sell 73.3 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
14.6569 USD |
|
6 years ago
Sep 07, 2018
|
Bought
100 K USD
|
JEFFS ROGER
Director
|
+ 7408
|
13.5646 USD |
|
6 years ago
Sep 07, 2018
|
Bought
27 K USD
|
PARKER H STEWART
Director
|
+ 2000
|
13.52 USD |
|
6 years ago
Sep 06, 2018
|
Sell 70.8 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
14.169 USD |
|
6 years ago
Aug 16, 2018
|
Sell 77 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
15.3903 USD |
|
6 years ago
Aug 06, 2018
|
Sell 67.2 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
13.45 USD |
|
6 years ago
Jul 16, 2018
|
Sell 73.9 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
14.772 USD |
|
6 years ago
Jul 06, 2018
|
Sell 79 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
15.795 USD |
|
6 years ago
Jun 15, 2018
|
Sell 78.4 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
15.673 USD |
|
6 years ago
Jun 06, 2018
|
Sell 83.4 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
16.67 USD |
|
6 years ago
May 15, 2018
|
Sell 76.9 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
15.384 USD |
|
6 years ago
May 07, 2018
|
Sell 81.8 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
16.3628 USD |
|
6 years ago
Apr 16, 2018
|
Sell 99.1 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
19.8288 USD |
|
6 years ago
Apr 13, 2018
|
Sell 163 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 8163
|
20 USD |
|
6 years ago
Apr 06, 2018
|
Sell 87.1 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
17.413 USD |
|
6 years ago
Apr 02, 2018
|
Sell 131 K
USD
|
Mento Steven J
Director
|
- 7115
|
18.3933 USD |
|
6 years ago
Apr 02, 2018
|
Sell 1.89 K
USD
|
Mento Steven J
Director
|
- 100
|
18.9 USD |
|
6 years ago
Apr 02, 2018
|
Sell 41.7 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 2278
|
18.2984 USD |
|
6 years ago
Mar 15, 2018
|
Sell 128 K
USD
|
Yi Kathy
SVP & Chief Financial Officer
|
- 5000
|
25.5624 USD |
|
6 years ago
Mar 06, 2018
|
Sell 124 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
24.7755 USD |
|
6 years ago
Mar 01, 2018
|
Sell 220 K
USD
|
Mento Steven J
Director
|
- 9433
|
23.2743 USD |
|
6 years ago
Mar 01, 2018
|
Sell 346 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 15000
|
23.0574 USD |
|
6 years ago
Feb 26, 2018
|
Sell 235 K
USD
|
Ramasastry Saira
Director
|
- 9450
|
24.8762 USD |
|
6 years ago
Feb 06, 2018
|
Sell 92.4 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
18.4871 USD |
|
6 years ago
Feb 01, 2018
|
Sell 237 K
USD
|
Mento Steven J
Director
|
- 11520
|
20.5867 USD |
|
6 years ago
Feb 01, 2018
|
Sell 309 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 15000
|
20.5903 USD |
|
7 years ago
Jan 08, 2018
|
Sell 85.5 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
17.109 USD |
|
7 years ago
Jan 02, 2018
|
Sell 114 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 6974
|
16.35 USD |
|
7 years ago
Jan 03, 2018
|
Sell 145 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 8026
|
18.05 USD |
|
7 years ago
Dec 06, 2017
|
Sell 81.2 K
USD
|
Conner Edward R.
Sr. VP & Chief Medical Officer
|
- 5000
|
16.24 USD |
|
7 years ago
Dec 04, 2017
|
Sell 212 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 11803
|
18 USD |
|
7 years ago
Nov 30, 2017
|
Sell 215 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 13433
|
16 USD |
|
7 years ago
Dec 01, 2017
|
Sell 53.4 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 3197
|
16.7 USD |
|
7 years ago
Nov 30, 2017
|
Sell 215 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 13433
|
16 USD |
|
7 years ago
Dec 01, 2017
|
Sell 53.4 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 3197
|
16.7 USD |
|
7 years ago
Nov 17, 2017
|
Sell 73.3 K
USD
|
Ramasastry Saira
Director
|
- 5000
|
14.6678 USD |
|
7 years ago
Oct 02, 2017
|
Sell 81.2 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 5416
|
15 USD |
|
7 years ago
Oct 02, 2017
|
Sell 60.1 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 3754
|
16 USD |
|
7 years ago
Sep 20, 2017
|
Sell 446 K
USD
|
RINGO WILLIAM R
Director
|
- 31000
|
14.3741 USD |
|
7 years ago
Sep 01, 2017
|
Sell 155 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 10316
|
15 USD |
|
7 years ago
Aug 11, 2017
|
Sell 64.7 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 6474
|
10 USD |
|
7 years ago
Aug 14, 2017
|
Sell 55 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 5000
|
11 USD |
|
7 years ago
Jul 14, 2017
|
Sell 1.72 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 172
|
10 USD |
|
7 years ago
Jul 14, 2017
|
Sell 148 K
USD
|
Herberts Curt A. III
Sr.VP & Chief Business Officer
|
- 14828
|
10 USD |
|
7 years ago
Jun 01, 2017
|
Sell 13.6 K
USD
|
Herberts Curt A. III
Senior VP & CBO
|
- 2000
|
6.8 USD |
|
7 years ago
May 11, 2017
|
Sell 4.15 K
USD
|
Herberts Curt A. III
Senior VP & CBO
|
- 639
|
6.5 USD |
|
7 years ago
May 12, 2017
|
Sell 17 K
USD
|
Herberts Curt A. III
Senior VP & CBO
|
- 2000
|
8.5 USD |
|
9 years ago
Jul 15, 2015
|
Sell 261 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
10.4308 USD |
|
9 years ago
Jul 13, 2015
|
Sell 39 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 3898
|
10 USD |
|
9 years ago
Jul 13, 2015
|
Sell 20 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
10 USD |
|
9 years ago
Jun 15, 2015
|
Sell 277 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
11.0831 USD |
|
9 years ago
Jun 10, 2015
|
Sell 122 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
12.2135 USD |
|
9 years ago
Jun 10, 2015
|
Sell 24.4 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
12.2117 USD |
|
9 years ago
Jun 05, 2015
|
Sell 184 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
12.2929 USD |
|
9 years ago
Jun 03, 2015
|
Sell 27.4 K
USD
|
RINGO WILLIAM R
Director
|
- 2200
|
12.4383 USD |
|
9 years ago
Jun 01, 2015
|
Sell 186 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
12.3877 USD |
|
9 years ago
May 15, 2015
|
Sell 288 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
11.5145 USD |
|
9 years ago
May 11, 2015
|
Sell 132 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
13.2456 USD |
|
9 years ago
May 11, 2015
|
Sell 26.5 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
13.2467 USD |
|
9 years ago
May 05, 2015
|
Sell 184 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
12.2865 USD |
|
9 years ago
May 04, 2015
|
Sell 38.9 K
USD
|
RINGO WILLIAM R
Director
|
- 3000
|
12.9758 USD |
|
9 years ago
May 01, 2015
|
Sell 189 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
12.6247 USD |
|
9 years ago
Apr 15, 2015
|
Sell 383 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
15.3304 USD |
|
9 years ago
Apr 10, 2015
|
Sell 153 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
15.2974 USD |
|
9 years ago
Apr 10, 2015
|
Sell 15 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 971
|
15.4317 USD |
|
9 years ago
Apr 10, 2015
|
Sell 15.8 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 1029
|
15.367 USD |
|
9 years ago
Apr 06, 2015
|
Sell 224 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
14.9448 USD |
|
9 years ago
Apr 06, 2015
|
Sell 32.9 K
USD
|
RINGO WILLIAM R
Director
|
- 2200
|
14.946 USD |
|
9 years ago
Apr 01, 2015
|
Sell 227 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
15.1461 USD |
|
9 years ago
Mar 19, 2015
|
Sell 180 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
18 USD |
|
9 years ago
Mar 16, 2015
|
Sell 432 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
17.2922 USD |
|
9 years ago
Mar 10, 2015
|
Sell 167 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
16.6836 USD |
|
9 years ago
Mar 10, 2015
|
Sell 33.4 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
16.6826 USD |
|
9 years ago
Mar 04, 2015
|
Sell 180 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
18 USD |
|
9 years ago
Mar 05, 2015
|
Sell 119 K
USD
|
Mento Steven J
Director
|
- 6501
|
18.2955 USD |
|
9 years ago
Mar 05, 2015
|
Sell 274 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
18.2855 USD |
|
9 years ago
Mar 03, 2015
|
Sell 37.9 K
USD
|
RINGO WILLIAM R
Director
|
- 2200
|
17.21 USD |
|
9 years ago
Mar 02, 2015
|
Sell 259 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
17.2625 USD |
|
9 years ago
Feb 17, 2015
|
Sell 392 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
15.686 USD |
|
10 years ago
Jun 05, 2014
|
Sell 936 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 66253
|
14.1305 USD |
|
10 years ago
Jun 05, 2014
|
Sell 690 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 48849
|
14.135 USD |
|
10 years ago
Jun 06, 2014
|
Sell 139 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 9852
|
14.0718 USD |
|
10 years ago
Jun 06, 2014
|
Sell 590 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 41749
|
14.13 USD |
|
10 years ago
Jun 06, 2014
|
Sell 1.2 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 83500
|
14.4 USD |
|
10 years ago
Jun 09, 2014
|
Sell 945 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 60955
|
15.4985 USD |
|
10 years ago
Jun 09, 2014
|
Sell 349 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 22545
|
15.5 USD |
|
10 years ago
Jun 16, 2014
|
Sell 30.1 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 1838
|
16.3541 USD |
|
10 years ago
Jun 16, 2014
|
Sell 61.1 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 3695
|
16.5231 USD |
|
10 years ago
Jun 16, 2014
|
Sell 2.27 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 137171
|
16.5235 USD |
|
10 years ago
Jun 16, 2014
|
Sell 1.79 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 107796
|
16.595 USD |
|
10 years ago
Jul 01, 2014
|
Sell 528 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 33080
|
15.955 USD |
|
10 years ago
Jul 17, 2014
|
Bought
456 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 37215
|
12.2588 USD |
|
10 years ago
Jul 01, 2014
|
Sell 796 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 49620
|
16.0461 USD |
|
10 years ago
Jul 24, 2014
|
Sell 1.52 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 124050
|
12.2792 USD |
|
10 years ago
Jul 25, 2014
|
Sell 584 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 47429
|
12.3121 USD |
|
10 years ago
Jul 28, 2014
|
Sell 300 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 24810
|
12.1 USD |
|
10 years ago
Jul 28, 2014
|
Sell 427 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 35271
|
12.114 USD |
|
10 years ago
Jul 29, 2014
|
Sell 17.5 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 1407
|
12.4122 USD |
|
10 years ago
Jul 30, 2014
|
Sell 254 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 20592
|
12.35 USD |
|
10 years ago
Jul 30, 2014
|
Sell 716 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 57890
|
12.36 USD |
|
10 years ago
Jul 30, 2014
|
Sell 392 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 31108
|
12.594 USD |
|
10 years ago
Aug 01, 2014
|
Sell 356 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 27770
|
12.8232 USD |
|
10 years ago
May 07, 2014
|
Bought
432 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 35736
|
12.085 USD |
|
10 years ago
May 08, 2014
|
Sell 258 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 20825
|
12.39 USD |
|
10 years ago
May 08, 2014
|
Sell 775 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 62475
|
12.398 USD |
|
10 years ago
May 12, 2014
|
Sell 252 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 19389
|
13.009 USD |
|
10 years ago
May 12, 2014
|
Sell 134 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 10270
|
13.0573 USD |
|
10 years ago
May 13, 2014
|
Sell 735 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 56060
|
13.1164 USD |
|
10 years ago
May 22, 2014
|
Sell 210 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 15578
|
13.5083 USD |
|
10 years ago
May 22, 2014
|
Sell 554 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 40818
|
13.575 USD |
|
10 years ago
May 23, 2014
|
Sell 685 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 51597
|
13.2704 USD |
|
10 years ago
May 27, 2014
|
Sell 2.09 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 154574
|
13.5502 USD |
|
10 years ago
May 27, 2014
|
Sell 1.48 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 108863
|
13.558 USD |
|
10 years ago
May 28, 2014
|
Sell 1.67 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 124387
|
13.4218 USD |
|
10 years ago
May 28, 2014
|
Sell 327 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 24302
|
13.4744 USD |
|
10 years ago
May 29, 2014
|
Sell 127 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 9390
|
13.5127 USD |
|
10 years ago
May 29, 2014
|
Sell 1.98 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 146285
|
13.533 USD |
|
10 years ago
May 30, 2014
|
Sell 557 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 41651
|
13.38 USD |
|
10 years ago
May 30, 2014
|
Sell 326 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 24233
|
13.4468 USD |
|
10 years ago
Jun 03, 2014
|
Sell 988 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 76833
|
12.86 USD |
|
10 years ago
Jun 04, 2014
|
Sell 270 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 20659
|
13.0803 USD |
|
10 years ago
Jun 04, 2014
|
Sell 273 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 20826
|
13.105 USD |
|
10 years ago
Jun 04, 2014
|
Sell 382 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 29155
|
13.105 USD |
|
10 years ago
Jun 05, 2014
|
Sell 11.9 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 918499
|
13 USD |
|
10 years ago
Jun 05, 2014
|
Sell 7.68 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 586
|
13.1071 USD |
|
10 years ago
Jun 05, 2014
|
Sell 257 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 18377
|
13.9771 USD |
|
10 years ago
Jun 05, 2014
|
Sell 465 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 32899
|
14.13 USD |
|
10 years ago
May 07, 2014
|
Bought
476 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 40566
|
11.735 USD |
|
10 years ago
May 07, 2014
|
Bought
81.9 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 6998
|
11.71 USD |
|
10 years ago
Apr 30, 2014
|
Bought
994 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 73289
|
13.5674 USD |
|
10 years ago
Apr 17, 2014
|
Bought
582 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 41500
|
14.0231 USD |
|
10 years ago
Apr 15, 2014
|
Bought
273 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 20750
|
13.16 USD |
|
10 years ago
Apr 11, 2014
|
Bought
492 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 33992
|
14.4875 USD |
|
10 years ago
Apr 22, 2014
|
Sell 582 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 39591
|
14.7031 USD |
|
10 years ago
Apr 15, 2014
|
Bought
14.1 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 1079
|
13.1008 USD |
|
10 years ago
Apr 14, 2014
|
Sell 45.2 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 3055
|
14.7841 USD |
|
10 years ago
Apr 16, 2014
|
Sell 308 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 21829
|
14.094 USD |
|
10 years ago
Apr 30, 2014
|
Bought
680 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 51211
|
13.285 USD |
|
10 years ago
Apr 11, 2014
|
Bought
1.2 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 83000
|
14.48 USD |
|
10 years ago
Apr 22, 2014
|
Sell 645 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 43409
|
14.8623 USD |
|
10 years ago
Apr 28, 2014
|
Bought
995 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 74844
|
13.2945 USD |
|
10 years ago
Apr 10, 2014
|
Bought
1.24 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 83000
|
14.9077 USD |
|
10 years ago
Apr 10, 2014
|
Sell 53.3 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 3403
|
15.6702 USD |
|
10 years ago
Apr 08, 2014
|
Bought
1.89 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 121876
|
15.4934 USD |
|
10 years ago
Apr 25, 2014
|
Bought
2.26 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 166000
|
13.6312 USD |
|
10 years ago
Apr 09, 2014
|
Sell 1.14 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 69856
|
16.2681 USD |
|
10 years ago
Apr 22, 2014
|
Sell 2.47 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 166000
|
14.8623 USD |
|
10 years ago
Apr 07, 2014
|
Bought
519 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 33667
|
15.4249 USD |
|
10 years ago
Apr 22, 2014
|
Sell 926 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 62250
|
14.875 USD |
|
10 years ago
Apr 04, 2014
|
Bought
2.75 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 179031
|
15.3812 USD |
|
10 years ago
Apr 22, 2014
|
Sell 623 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 41500
|
15.0159 USD |
|
10 years ago
Apr 03, 2014
|
Bought
3.24 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 195126
|
16.6149 USD |
|
10 years ago
Mar 28, 2014
|
Bought
1.06 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 62160
|
17.105 USD |
|
10 years ago
Apr 01, 2014
|
Sell 867 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 48500
|
17.8751 USD |
|
10 years ago
Mar 28, 2014
|
Bought
373 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 21840
|
17.07 USD |
|
10 years ago
Apr 01, 2014
|
Sell 445 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 24900
|
17.885 USD |
|
10 years ago
Mar 27, 2014
|
Bought
4.45 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 251987
|
17.6576 USD |
|
10 years ago
Apr 01, 2014
|
Sell 897 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 50000
|
17.945 USD |
|
10 years ago
Apr 01, 2014
|
Sell 931 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 51500
|
18.076 USD |
|
10 years ago
Apr 01, 2014
|
Sell 1.36 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 75100
|
18.135 USD |
|
10 years ago
Mar 27, 2014
|
Bought
72.9 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 4200
|
17.35 USD |
|
10 years ago
Mar 26, 2014
|
Bought
3.46 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 190693
|
18.162 USD |
|
10 years ago
Mar 26, 2014
|
Bought
345 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 19320
|
17.875 USD |
|
10 years ago
Mar 25, 2014
|
Bought
409 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 21000
|
19.455 USD |
|
10 years ago
Mar 25, 2014
|
Bought
817 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 42000
|
19.4418 USD |
|
10 years ago
Mar 25, 2014
|
Bought
406 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 21000
|
19.33 USD |
|
10 years ago
Mar 18, 2014
|
Sell 818 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 34440
|
23.7448 USD |
|
10 years ago
Mar 12, 2014
|
Sell 2.89 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 123480
|
23.4 USD |
|
10 years ago
Mar 13, 2014
|
Bought
1.62 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 71319
|
22.7619 USD |
|
10 years ago
Mar 17, 2014
|
Bought
1.2 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 52161
|
23.0217 USD |
|
10 years ago
Mar 18, 2014
|
Sell 1.18 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 49560
|
23.745 USD |
|
10 years ago
Mar 19, 2014
|
Sell 432 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 17808
|
24.283 USD |
|
10 years ago
Mar 07, 2014
|
Bought
5.75 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 258377
|
22.2487 USD |
|
10 years ago
Mar 10, 2014
|
Bought
279 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 12522
|
22.2952 USD |
|
10 years ago
Mar 21, 2014
|
Bought
2.16 M USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 101808
|
21.2163 USD |
|
10 years ago
Mar 06, 2014
|
Sell 975 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 40482
|
24.095 USD |
|
10 years ago
Mar 06, 2014
|
Sell 506 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 21001
|
24.1 USD |
|
10 years ago
Feb 12, 2014
|
Bought
758 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 42000
|
18.0386 USD |
|
10 years ago
Feb 28, 2014
|
Bought
760 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 42000
|
18.0987 USD |
|
10 years ago
Feb 26, 2014
|
Bought
836 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 42000
|
19.8982 USD |
|
10 years ago
Feb 13, 2014
|
Sell 284 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 15409
|
18.4592 USD |
|
10 years ago
Feb 27, 2014
|
Sell 288 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 14953
|
19.26 USD |
|
10 years ago
Feb 14, 2014
|
Sell 286 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 15380
|
18.6064 USD |
|
10 years ago
Feb 18, 2014
|
Sell 202 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 11172
|
18.1058 USD |
|
10 years ago
Feb 11, 2014
|
Bought
825 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 42000
|
19.6494 USD |
|
10 years ago
Feb 05, 2014
|
Bought
196 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 10666
|
18.3623 USD |
|
10 years ago
Feb 27, 2014
|
Sell 336 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 17243
|
19.4574 USD |
|
10 years ago
Feb 19, 2014
|
Sell 124 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 6720
|
18.5149 USD |
|
10 years ago
Feb 20, 2014
|
Sell 717
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 39
|
18.39 USD |
|
10 years ago
Feb 06, 2014
|
Sell 135 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 7312
|
18.4194 USD |
|
10 years ago
Feb 26, 2014
|
Bought
617 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 32194
|
19.1501 USD |
|
10 years ago
Feb 05, 2014
|
Bought
321 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 17640
|
18.21 USD |
|
10 years ago
Mar 03, 2014
|
Sell 1.22 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 67200
|
18.21 USD |
|
10 years ago
Feb 05, 2014
|
Bought
249 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 13694
|
18.165 USD |
|
10 years ago
Feb 07, 2014
|
Sell 642 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 34688
|
18.5203 USD |
|
10 years ago
Feb 20, 2014
|
Sell 649 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 35280
|
18.4 USD |
|
10 years ago
Mar 06, 2014
|
Sell 5.61 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 241471
|
23.235 USD |
|
10 years ago
Mar 06, 2014
|
Sell 490 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 20415
|
24.0014 USD |
|
10 years ago
Mar 06, 2014
|
Sell 731 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 31531
|
23.1786 USD |
|
10 years ago
Mar 06, 2014
|
Bought
948 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 42000
|
22.5603 USD |
|
10 years ago
Mar 06, 2014
|
Bought
943 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 42001
|
22.445 USD |
|
10 years ago
Mar 03, 2014
|
Sell 306 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 16800
|
18.2256 USD |
|
10 years ago
Jan 29, 2014
|
Sell 290 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 8275
|
35 USD |
|
10 years ago
Jan 29, 2014
|
Sell 248 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 8275
|
30 USD |
|
10 years ago
Jan 29, 2014
|
Bought
166 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 8275
|
20 USD |
|
10 years ago
Jan 29, 2014
|
Bought
207 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 8275
|
25 USD |
|
11 years ago
Dec 13, 2013
|
Bought
60.9 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 5040
|
12.0875 USD |
|
11 years ago
Dec 12, 2013
|
Bought
116 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 9600
|
12.0907 USD |
|
11 years ago
Jan 09, 2014
|
Sell 508 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 27483
|
18.4678 USD |
|
11 years ago
Jan 09, 2014
|
Sell 822 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 44957
|
18.28 USD |
|
11 years ago
Jul 17, 2013
|
Bought
188 K USD
|
RA CAPITAL MANAGEMENT, LLC
|
+ 19200
|
9.7862 USD |
|
11 years ago
Jul 17, 2013
|
Sell 297 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 29070
|
10.2129 USD |
|
11 years ago
Jul 17, 2013
|
Sell 197 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 19200
|
10.235 USD |
|
11 years ago
Jul 18, 2013
|
Sell 741 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 74035
|
10.0155 USD |
|
11 years ago
Jul 19, 2013
|
Sell 225 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 23040
|
9.7744 USD |
|
11 years ago
Jul 19, 2013
|
Sell 1.04 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 105522
|
9.85 USD |
|
11 years ago
Jul 22, 2013
|
Sell 734 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 76801
|
9.56 USD |
|
11 years ago
Jul 22, 2013
|
Sell 110 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 11520
|
9.565 USD |
|
11 years ago
Jul 22, 2013
|
Sell 221 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 23042
|
9.6 USD |
|
11 years ago
Jul 23, 2013
|
Sell 46.9 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 5012
|
9.3652 USD |
|
11 years ago
Jul 25, 2013
|
Sell 38.7 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 4071
|
9.5135 USD |
|
11 years ago
Jul 25, 2013
|
Sell 1.82 M
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 191999
|
9.495 USD |
|
11 years ago
Jul 25, 2013
|
Sell 192 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 19200
|
10 USD |
|
11 years ago
Jul 25, 2013
|
Sell 761 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 76800
|
9.91 USD |
|
11 years ago
Jul 25, 2013
|
Sell 768 K
USD
|
RA CAPITAL MANAGEMENT, LLC
|
- 76800
|
10 USD |
|
9 years ago
Feb 12, 2015
|
Sell 150 K
USD
|
Ramasastry Saira
Director
|
- 10000
|
15 USD |
|
9 years ago
Feb 10, 2015
|
Sell 126 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
12.6473 USD |
|
9 years ago
Feb 10, 2015
|
Sell 12.3 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 971
|
12.63 USD |
|
9 years ago
Feb 10, 2015
|
Sell 13 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 1029
|
12.647 USD |
|
9 years ago
Feb 05, 2015
|
Sell 194 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
12.93 USD |
|
9 years ago
Feb 03, 2015
|
Sell 27.9 K
USD
|
RINGO WILLIAM R
Director
|
- 2200
|
12.7 USD |
|
9 years ago
Feb 02, 2015
|
Sell 193 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
12.8553 USD |
|
10 years ago
Jan 15, 2015
|
Sell 189 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 13400
|
14.0912 USD |
|
10 years ago
Jan 15, 2015
|
Sell 23.9 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 1600
|
14.9666 USD |
|
10 years ago
Jan 16, 2015
|
Sell 143 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 10000
|
14.2853 USD |
|
10 years ago
Jan 12, 2015
|
Sell 159 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
15.871 USD |
|
10 years ago
Jan 12, 2015
|
Sell 31.7 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
15.87 USD |
|
10 years ago
Jan 05, 2015
|
Sell 33.4 K
USD
|
RINGO WILLIAM R
Director
|
- 2200
|
15.1954 USD |
|
10 years ago
Jan 05, 2015
|
Sell 227 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 15000
|
15.1033 USD |
|
10 years ago
Jan 02, 2015
|
Sell 237 K
USD
|
Gregory Philip D
SVP, Research & CSO
|
- 15000
|
15.7776 USD |
|
10 years ago
Jan 05, 2015
|
Sell 218 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 14400
|
15.1708 USD |
|
10 years ago
Jan 05, 2015
|
Sell 9.39 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 600
|
15.6567 USD |
|
10 years ago
Dec 15, 2014
|
Sell 148 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 9000
|
16.4706 USD |
|
10 years ago
Dec 15, 2014
|
Sell 237 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 16000
|
14.7923 USD |
|
10 years ago
Dec 15, 2014
|
Sell 163 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 10000
|
16.2829 USD |
|
10 years ago
Dec 11, 2014
|
Sell 95.3 K
USD
|
Mento Steven J
Director
|
- 6354
|
15 USD |
|
10 years ago
Dec 05, 2014
|
Sell 168 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
11.2131 USD |
|
10 years ago
Dec 09, 2014
|
Sell 120 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 10000
|
12 USD |
|
10 years ago
Dec 01, 2014
|
Sell 175 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
11.6794 USD |
|
10 years ago
Nov 17, 2014
|
Sell 281 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
11.2337 USD |
|
10 years ago
Nov 10, 2014
|
Sell 22.7 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
11.3741 USD |
|
10 years ago
Nov 12, 2014
|
Sell 120 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 10000
|
12.0007 USD |
|
10 years ago
Nov 05, 2014
|
Sell 170 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
11.3505 USD |
|
10 years ago
Nov 03, 2014
|
Sell 179 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
11.9136 USD |
|
10 years ago
Oct 28, 2014
|
Sell 120 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 10000
|
12.0153 USD |
|
10 years ago
Oct 15, 2014
|
Sell 262 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
10.4946 USD |
|
10 years ago
Oct 10, 2014
|
Sell 20.2 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
10.1 USD |
|
10 years ago
Oct 06, 2014
|
Sell 161 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
10.7243 USD |
|
10 years ago
Oct 01, 2014
|
Sell 162 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
10.8019 USD |
|
10 years ago
Sep 15, 2014
|
Sell 303 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
12.1353 USD |
|
10 years ago
Sep 10, 2014
|
Sell 24.6 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
12.31 USD |
|
10 years ago
Sep 05, 2014
|
Sell 183 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
12.2048 USD |
|
10 years ago
Sep 04, 2014
|
Sell 128 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 10000
|
12.8082 USD |
|
10 years ago
Sep 02, 2014
|
Sell 202 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
13.4532 USD |
|
10 years ago
Aug 15, 2014
|
Sell 349 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
13.9519 USD |
|
10 years ago
Aug 08, 2014
|
Sell 140 K
USD
|
Ramasastry Saira
Director
|
- 10000
|
14 USD |
|
10 years ago
Aug 11, 2014
|
Sell 113 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 8000
|
14.1738 USD |
|
10 years ago
Aug 11, 2014
|
Sell 28.3 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
14.1435 USD |
|
10 years ago
Aug 05, 2014
|
Sell 172 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 13202
|
12.991 USD |
|
10 years ago
Aug 05, 2014
|
Sell 23.3 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1798
|
12.9803 USD |
|
10 years ago
Aug 04, 2014
|
Sell 126 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 10000
|
12.5578 USD |
|
10 years ago
Aug 01, 2014
|
Sell 188 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
12.5433 USD |
|
10 years ago
Jul 18, 2014
|
Sell 304 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
12.1576 USD |
|
10 years ago
Jul 10, 2014
|
Sell 173 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 13000
|
13.2713 USD |
|
10 years ago
Jul 10, 2014
|
Sell 26.4 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
13.1875 USD |
|
10 years ago
Jul 01, 2014
|
Sell 235 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
15.6577 USD |
|
10 years ago
Jun 23, 2014
|
Sell 86.2 K
USD
|
Ramasastry Saira
Director
|
- 5550
|
15.5346 USD |
|
10 years ago
Jun 16, 2014
|
Sell 410 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
16.4055 USD |
|
10 years ago
Jun 09, 2014
|
Sell 64.9 K
USD
|
Mento Steven J
Director
|
- 4328
|
15 USD |
|
10 years ago
Jun 10, 2014
|
Sell 203 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 13000
|
15.6211 USD |
|
10 years ago
Jun 10, 2014
|
Sell 31.3 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
15.627 USD |
|
10 years ago
Jun 02, 2014
|
Sell 193 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
12.8482 USD |
|
10 years ago
May 27, 2014
|
Sell 176 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 13000
|
13.569 USD |
|
10 years ago
May 27, 2014
|
Sell 27.1 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
13.567 USD |
|
10 years ago
May 15, 2014
|
Sell 329 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
13.1417 USD |
|
10 years ago
May 12, 2014
|
Sell 167 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 13000
|
12.8507 USD |
|
10 years ago
May 12, 2014
|
Sell 25.7 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
12.8482 USD |
|
10 years ago
May 01, 2014
|
Sell 205 K
USD
|
Gregory Philip D
SVP of Research & CSO
|
- 15000
|
13.6786 USD |
|
10 years ago
Apr 28, 2014
|
Sell 27.3 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
13.6276 USD |
|
10 years ago
Apr 28, 2014
|
Sell 177 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 13000
|
13.6367 USD |
|
10 years ago
Apr 28, 2014
|
Sell 135 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 10000
|
13.4786 USD |
|
10 years ago
Apr 15, 2014
|
Sell 355 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
14.2005 USD |
|
10 years ago
Apr 10, 2014
|
Sell 204 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 13000
|
15.7171 USD |
|
10 years ago
Apr 10, 2014
|
Sell 31.5 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 2000
|
15.7379 USD |
|
10 years ago
Apr 01, 2014
|
Sell 267 K
USD
|
Gregory Philip D
Sr. VP Res. & CSO
|
- 15000
|
17.8 USD |
|
10 years ago
Mar 26, 2014
|
Sell 239 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 12800
|
18.64 USD |
|
10 years ago
Mar 26, 2014
|
Sell 37.3 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
18.6417 USD |
|
10 years ago
Mar 26, 2014
|
Sell 3.82 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 200
|
19.1 USD |
|
10 years ago
Mar 21, 2014
|
Sell 336 K
USD
|
Gregory Philip D
See Remarks
|
- 15000
|
22.3842 USD |
|
10 years ago
Mar 17, 2014
|
Sell 233 K
USD
|
Ramasastry Saira
Director
|
- 10000
|
23.2608 USD |
|
10 years ago
Mar 14, 2014
|
Sell 139 K
USD
|
Mento Steven J
Director
|
- 6103
|
22.7683 USD |
|
10 years ago
Mar 17, 2014
|
Sell 1.16 M
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 50000
|
23.2186 USD |
|
10 years ago
Mar 10, 2014
|
Sell 223 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
22.3071 USD |
|
10 years ago
Feb 26, 2014
|
Sell 39.5 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
19.7258 USD |
|
10 years ago
Feb 26, 2014
|
Sell 256 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 13000
|
19.7154 USD |
|
10 years ago
Feb 18, 2014
|
Sell 904 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 50000
|
18.087 USD |
|
10 years ago
Feb 14, 2014
|
Sell 452 K
USD
|
RINGO WILLIAM R
Director
|
- 25000
|
18.063 USD |
|
10 years ago
Feb 10, 2014
|
Sell 193 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
19.2638 USD |
|
10 years ago
Feb 03, 2014
|
Sell 283 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 15000
|
18.8344 USD |
|
10 years ago
Jan 27, 2014
|
Sell 37.5 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
18.7273 USD |
|
10 years ago
Jan 27, 2014
|
Sell 241 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 13000
|
18.5596 USD |
|
11 years ago
Jan 15, 2014
|
Sell 926 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 50000
|
18.5135 USD |
|
11 years ago
Jan 15, 2014
|
Sell 156 K
USD
|
Cleveland Paul B
Director
|
- 8333
|
18.684 USD |
|
11 years ago
Jan 10, 2014
|
Sell 187 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
18.6893 USD |
|
11 years ago
Jan 02, 2014
|
Sell 203 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 15000
|
13.556 USD |
|
11 years ago
Dec 26, 2013
|
Sell 187 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 13000
|
14.387 USD |
|
11 years ago
Dec 26, 2013
|
Sell 28.4 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
14.223 USD |
|
11 years ago
Dec 18, 2013
|
Sell 624 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 50000
|
12.4741 USD |
|
11 years ago
Dec 10, 2013
|
Sell 120 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
11.967 USD |
|
11 years ago
Dec 02, 2013
|
Sell 175 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 15000
|
11.6557 USD |
|
11 years ago
Dec 02, 2013
|
Sell 116 K
USD
|
Cleveland Paul B
Director
|
- 10000
|
11.6393 USD |
|
11 years ago
Nov 26, 2013
|
Sell 35.5 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 3000
|
11.8253 USD |
|
11 years ago
Nov 26, 2013
|
Sell 142 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 12000
|
11.8252 USD |
|
11 years ago
Nov 13, 2013
|
Sell 100 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
10 USD |
|
11 years ago
Nov 15, 2013
|
Sell 253 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
10.1089 USD |
|
11 years ago
Nov 05, 2013
|
Sell 70 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 7000
|
10 USD |
|
11 years ago
Nov 01, 2013
|
Sell 74.1 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 8000
|
9.2581 USD |
|
11 years ago
Oct 28, 2013
|
Sell 31.2 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 3000
|
10.3853 USD |
|
11 years ago
Oct 21, 2013
|
Sell 109 K
USD
|
Cleveland Paul B
Director
|
- 10000
|
10.9336 USD |
|
11 years ago
Oct 15, 2013
|
Sell 283 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
11.3233 USD |
|
11 years ago
Oct 10, 2013
|
Sell 113 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
11.2763 USD |
|
11 years ago
Oct 01, 2013
|
Sell 158 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 15000
|
10.5387 USD |
|
11 years ago
Sep 26, 2013
|
Sell 127 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 12000
|
10.5742 USD |
|
11 years ago
Sep 26, 2013
|
Sell 31.7 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 3000
|
10.5613 USD |
|
11 years ago
Sep 16, 2013
|
Sell 282 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
11.2851 USD |
|
11 years ago
Sep 10, 2013
|
Sell 109 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
10.8593 USD |
|
11 years ago
Sep 03, 2013
|
Sell 155 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 15000
|
10.3321 USD |
|
11 years ago
Sep 03, 2013
|
Sell 75 K
USD
|
Cleveland Paul B
Director
|
- 7278
|
10.302 USD |
|
11 years ago
Aug 26, 2013
|
Sell 110 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 11000
|
10.0412 USD |
|
11 years ago
Aug 26, 2013
|
Sell 20.1 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
10.0383 USD |
|
11 years ago
Aug 26, 2013
|
Sell 20.1 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
10.0383 USD |
|
11 years ago
Aug 15, 2013
|
Sell 253 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
10.1152 USD |
|
11 years ago
Aug 13, 2013
|
Sell 100 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
10 USD |
|
11 years ago
Aug 01, 2013
|
Sell 148 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 15000
|
9.8881 USD |
|
11 years ago
Jul 26, 2013
|
Sell 20.2 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
10.1195 USD |
|
11 years ago
Jul 26, 2013
|
Sell 111 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 11000
|
10.0752 USD |
|
11 years ago
Jul 26, 2013
|
Sell 20.2 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
10.121 USD |
|
11 years ago
Jul 29, 2013
|
Sell 80.1 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 8000
|
10.0179 USD |
|
11 years ago
Jul 29, 2013
|
Sell 70.4 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 7000
|
10.0589 USD |
|
11 years ago
Jul 17, 2013
|
Sell 250 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
10.0001 USD |
|
11 years ago
Jul 17, 2013
|
Sell 100 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
10 USD |
|
11 years ago
Jul 15, 2013
|
Sell 76.7 K
USD
|
Cleveland Paul B
Director
|
- 8000
|
9.5897 USD |
|
11 years ago
Jun 03, 2013
|
Sell 23.6 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 3000
|
7.88 USD |
|
11 years ago
May 28, 2013
|
Sell 125 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
8.3212 USD |
|
11 years ago
May 01, 2013
|
Sell 60.6 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 6000
|
10.0928 USD |
|
11 years ago
Apr 26, 2013
|
Sell 161 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
10.7164 USD |
|
11 years ago
Apr 15, 2013
|
Sell 50 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 5000
|
10 USD |
|
11 years ago
Apr 16, 2013
|
Sell 1.9 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 190
|
10 USD |
|
11 years ago
Apr 10, 2013
|
Sell 100 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
10 USD |
|
11 years ago
Apr 01, 2013
|
Sell 57.2 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 6000
|
9.54 USD |
|
11 years ago
Mar 26, 2013
|
Sell 138 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
9.1816 USD |
|
11 years ago
Mar 01, 2013
|
Sell 60 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 6000
|
10.0009 USD |
|
11 years ago
Feb 28, 2013
|
Sell 100 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
10 USD |
|
11 years ago
Feb 28, 2013
|
Sell 250 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 25000
|
10 USD |
|
11 years ago
Feb 26, 2013
|
Sell 130 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
8.64 USD |
|
11 years ago
Jan 28, 2013
|
Sell 145 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
9.6772 USD |
|
11 years ago
Feb 01, 2013
|
Sell 57.2 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 6000
|
9.5325 USD |
|
12 years ago
Jan 28, 2012
|
Sell 145 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
9.6772 USD |
|
11 years ago
Jan 23, 2013
|
Sell 100 K
USD
|
Wolff Henry Ward
Exec VP & CFO
|
- 10000
|
10 USD |
|
11 years ago
Jan 23, 2013
|
Sell 83 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 8300
|
10.001 USD |
|
11 years ago
Jan 24, 2013
|
Sell 3 K
USD
|
LANPHIER EDWARD O II
President & CEO
|
- 300
|
10 USD |
|
12 years ago
Jan 02, 2013
|
Sell 36.3 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 6000
|
6.05 USD |
|
12 years ago
Dec 26, 2012
|
Sell 11.9 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 2000
|
5.944 USD |
|
12 years ago
Dec 26, 2012
|
Sell 88.8 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
5.922 USD |
|
12 years ago
Dec 10, 2012
|
Sell 59 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 12000
|
4.92 USD |
|
12 years ago
Dec 10, 2012
|
Sell 72 K
USD
|
Gregory Philip D
Vice President, Research & CSO
|
- 12000
|
6 USD |
|
12 years ago
Dec 03, 2012
|
Sell 5.48 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1000
|
5.48 USD |
|
12 years ago
Dec 03, 2012
|
Sell 17.7 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 3195
|
5.54 USD |
|
12 years ago
Dec 03, 2012
|
Sell 560
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.6 USD |
|
12 years ago
Dec 03, 2012
|
Sell 10.1 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1805
|
5.61 USD |
|
12 years ago
Dec 03, 2012
|
Sell 1.69 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 300
|
5.62 USD |
|
12 years ago
Dec 03, 2012
|
Sell 563
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.63 USD |
|
12 years ago
Dec 03, 2012
|
Sell 3.41 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 600
|
5.69 USD |
|
12 years ago
Dec 03, 2012
|
Sell 2.28 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 400
|
5.7 USD |
|
12 years ago
Dec 03, 2012
|
Sell 42.8 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 7500
|
5.71 USD |
|
12 years ago
Nov 27, 2012
|
Sell 84 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
5.6 USD |
|
12 years ago
Nov 26, 2012
|
Sell 25.2 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 4736
|
5.3278 USD |
|
12 years ago
Nov 01, 2012
|
Sell 82.8 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 15000
|
5.5176 USD |
|
12 years ago
Oct 26, 2012
|
Sell 85.3 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
5.689 USD |
|
12 years ago
Oct 26, 2012
|
Sell 28.6 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 5000
|
5.72 USD |
|
12 years ago
Oct 17, 2012
|
Sell 36 K
USD
|
Gregory Philip D
VP, Therapeutic Dev. & CMO
|
- 6000
|
6 USD |
|
12 years ago
Oct 15, 2012
|
Sell 5.72 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1000
|
5.7233 USD |
|
12 years ago
Oct 15, 2012
|
Sell 79.9
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 14
|
5.71 USD |
|
12 years ago
Oct 15, 2012
|
Sell 1.06 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 186
|
5.7 USD |
|
12 years ago
Oct 15, 2012
|
Sell 2.85 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 500
|
5.6933 USD |
|
12 years ago
Oct 15, 2012
|
Sell 1.71 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 300
|
5.6922 USD |
|
12 years ago
Oct 15, 2012
|
Sell 8.43 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1500
|
5.6233 USD |
|
12 years ago
Oct 15, 2012
|
Sell 8.43 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1500
|
5.6201 USD |
|
12 years ago
Oct 01, 2012
|
Sell 1.84 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 300
|
6.15 USD |
|
12 years ago
Oct 01, 2012
|
Sell 3.12 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 506
|
6.16 USD |
|
12 years ago
Oct 01, 2012
|
Sell 11.5 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1869
|
6.17 USD |
|
12 years ago
Oct 01, 2012
|
Sell 7.77 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1258
|
6.18 USD |
|
12 years ago
Oct 01, 2012
|
Sell 6.16 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 995
|
6.19 USD |
|
12 years ago
Oct 01, 2012
|
Sell 360
USD
|
LARSON JOHN WILLIAM
Director
|
- 58
|
6.2 USD |
|
12 years ago
Oct 01, 2012
|
Sell 41.5 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 6676
|
6.21 USD |
|
12 years ago
Oct 01, 2012
|
Sell 12.1 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1940
|
6.22 USD |
|
12 years ago
Oct 01, 2012
|
Sell 8.72 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1398
|
6.24 USD |
|
12 years ago
Sep 05, 2012
|
Sell 84 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
5.6 USD |
|
12 years ago
Sep 04, 2012
|
Sell 520
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.2 USD |
|
12 years ago
Sep 04, 2012
|
Sell 3.13 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 601
|
5.21 USD |
|
12 years ago
Sep 04, 2012
|
Sell 2.61 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 500
|
5.22 USD |
|
12 years ago
Sep 04, 2012
|
Sell 523
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.23 USD |
|
12 years ago
Sep 04, 2012
|
Sell 524
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.24 USD |
|
12 years ago
Sep 04, 2012
|
Sell 1.57 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 299
|
5.25 USD |
|
12 years ago
Sep 04, 2012
|
Sell 5.62 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1068
|
5.26 USD |
|
12 years ago
Sep 04, 2012
|
Sell 2.26 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 429
|
5.27 USD |
|
12 years ago
Sep 04, 2012
|
Sell 14.3 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 2702
|
5.3 USD |
|
12 years ago
Sep 04, 2012
|
Sell 4.26 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 803
|
5.31 USD |
|
12 years ago
Sep 04, 2012
|
Sell 40.4 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 7603
|
5.32 USD |
|
12 years ago
Sep 04, 2012
|
Sell 1.04 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 196
|
5.3201 USD |
|
12 years ago
Sep 04, 2012
|
Sell 1.6 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 300
|
5.33 USD |
|
12 years ago
Sep 04, 2012
|
Sell 529
USD
|
LARSON JOHN WILLIAM
Director
|
- 99
|
5.34 USD |
|
12 years ago
Sep 04, 2012
|
Sell 535
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.35 USD |
|
12 years ago
Aug 27, 2012
|
Sell 6.03 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1170
|
5.15 USD |
|
12 years ago
Aug 27, 2012
|
Sell 8.41 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1630
|
5.16 USD |
|
12 years ago
Aug 27, 2012
|
Sell 1.03 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 200
|
5.17 USD |
|
12 years ago
Aug 27, 2012
|
Sell 2.87 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 550
|
5.21 USD |
|
12 years ago
Aug 27, 2012
|
Sell 5.22 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1000
|
5.2155 USD |
|
12 years ago
Aug 27, 2012
|
Sell 1.04 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 200
|
5.22 USD |
|
12 years ago
Aug 27, 2012
|
Sell 1.31 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 250
|
5.2301 USD |
|
12 years ago
Aug 01, 2012
|
Sell 3.64 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 700
|
5.2 USD |
|
12 years ago
Aug 01, 2012
|
Sell 12.5 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 2400
|
5.21 USD |
|
12 years ago
Aug 01, 2012
|
Sell 7.83 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1500
|
5.22 USD |
|
12 years ago
Aug 01, 2012
|
Sell 4.18 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 800
|
5.23 USD |
|
12 years ago
Aug 01, 2012
|
Sell 524
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.235 USD |
|
12 years ago
Aug 01, 2012
|
Sell 526
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.26 USD |
|
12 years ago
Aug 01, 2012
|
Sell 7.9 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1500
|
5.27 USD |
|
12 years ago
Aug 01, 2012
|
Sell 41.7 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 7900
|
5.28 USD |
|
12 years ago
Jul 26, 2012
|
Sell 5.12 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1000
|
5.12 USD |
|
12 years ago
Jul 26, 2012
|
Sell 7.64 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1500
|
5.09 USD |
|
12 years ago
Jul 26, 2012
|
Sell 7.56 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 1500
|
5.04 USD |
|
12 years ago
Jul 26, 2012
|
Sell 2.51 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 500
|
5.02 USD |
|
12 years ago
Jul 26, 2012
|
Sell 2.5 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 500
|
4.99 USD |
|
12 years ago
Jul 27, 2012
|
Sell 84 K
USD
|
ANDO DALE G
VP, Therapeutic Dev. & CMO
|
- 15000
|
5.6 USD |
|
12 years ago
Jul 02, 2012
|
Sell 8.01 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1541
|
5.2 USD |
|
12 years ago
Jul 02, 2012
|
Sell 1.04 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 200
|
5.2001 USD |
|
12 years ago
Jul 02, 2012
|
Sell 520
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.205 USD |
|
12 years ago
Jul 02, 2012
|
Sell 2.08 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 400
|
5.21 USD |
|
12 years ago
Jul 02, 2012
|
Sell 522
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.215 USD |
|
12 years ago
Jul 02, 2012
|
Sell 7.69 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1473
|
5.22 USD |
|
12 years ago
Jul 02, 2012
|
Sell 522
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.2201 USD |
|
12 years ago
Jul 02, 2012
|
Sell 10.1 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1927
|
5.23 USD |
|
12 years ago
Jul 02, 2012
|
Sell 523
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.2301 USD |
|
12 years ago
Jul 02, 2012
|
Sell 524
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.235 USD |
|
12 years ago
Jul 02, 2012
|
Sell 21.5 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 4100
|
5.24 USD |
|
12 years ago
Jul 02, 2012
|
Sell 8.4 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1600
|
5.25 USD |
|
12 years ago
Jul 02, 2012
|
Sell 13.2 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 2500
|
5.26 USD |
|
12 years ago
Jul 02, 2012
|
Sell 1.89 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 359
|
5.27 USD |
|
12 years ago
Jul 02, 2012
|
Sell 528
USD
|
LARSON JOHN WILLIAM
Director
|
- 100
|
5.28 USD |
|
12 years ago
Jul 02, 2012
|
Sell 1.59 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 300
|
5.29 USD |
|
12 years ago
Jun 15, 2012
|
Sell 75 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 15000
|
5 USD |
|
13 years ago
Sep 09, 2011
|
Sell 15 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 2500
|
6 USD |
|
13 years ago
Jul 07, 2011
|
Sell 25.9 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 4000
|
6.47 USD |
|
13 years ago
Jul 01, 2011
|
Sell 90 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 15000
|
6 USD |
|
13 years ago
Jun 06, 2011
|
Sell 26.1 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 4000
|
6.52 USD |
|
13 years ago
Jun 01, 2011
|
Sell 723
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 106
|
6.82 USD |
|
13 years ago
Jun 01, 2011
|
Sell 6.81 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1000
|
6.81 USD |
|
13 years ago
Jun 01, 2011
|
Sell 94.5 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 13894
|
6.8 USD |
|
13 years ago
May 05, 2011
|
Sell 27 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 4000
|
6.74 USD |
|
13 years ago
May 02, 2011
|
Sell 11 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1500
|
7.3 USD |
|
13 years ago
May 02, 2011
|
Sell 7.3 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1000
|
7.305 USD |
|
13 years ago
May 02, 2011
|
Sell 11.7 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1600
|
7.31 USD |
|
13 years ago
May 02, 2011
|
Sell 739
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 101
|
7.315 USD |
|
13 years ago
May 02, 2011
|
Sell 2.19 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 299
|
7.32 USD |
|
13 years ago
May 02, 2011
|
Sell 5.86 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 800
|
7.33 USD |
|
13 years ago
May 02, 2011
|
Sell 16.1 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 2200
|
7.335 USD |
|
13 years ago
May 02, 2011
|
Sell 54.3 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 7400
|
7.34 USD |
|
13 years ago
May 02, 2011
|
Sell 735
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 100
|
7.35 USD |
|
13 years ago
Apr 25, 2011
|
Sell 12.4 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1648
|
7.5 USD |
|
13 years ago
Apr 25, 2011
|
Sell 7.4 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 985
|
7.51 USD |
|
13 years ago
Apr 25, 2011
|
Sell 12 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1600
|
7.52 USD |
|
13 years ago
Apr 25, 2011
|
Sell 678
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 90
|
7.53 USD |
|
13 years ago
Apr 25, 2011
|
Sell 52.8 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 7005
|
7.54 USD |
|
13 years ago
Apr 25, 2011
|
Sell 1.51 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 200
|
7.545 USD |
|
13 years ago
Apr 25, 2011
|
Sell 37 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 4900
|
7.55 USD |
|
13 years ago
Apr 25, 2011
|
Sell 6.04 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 800
|
7.555 USD |
|
13 years ago
Apr 25, 2011
|
Sell 2.27 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 300
|
7.5575 USD |
|
13 years ago
Apr 25, 2011
|
Sell 12.9 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1705
|
7.56 USD |
|
13 years ago
Apr 25, 2011
|
Sell 1.52 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 200
|
7.59 USD |
|
13 years ago
Apr 21, 2011
|
Sell 764
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 100
|
7.64 USD |
|
13 years ago
Apr 21, 2011
|
Sell 2.46 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 322
|
7.65 USD |
|
13 years ago
Apr 21, 2011
|
Sell 2.92 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 381
|
7.66 USD |
|
13 years ago
Apr 21, 2011
|
Sell 11.5 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 1500
|
7.67 USD |
|
13 years ago
Apr 21, 2011
|
Sell 9.75 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 1269
|
7.68 USD |
|
13 years ago
Apr 21, 2011
|
Sell 770
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 100
|
7.7 USD |
|
13 years ago
Apr 21, 2011
|
Sell 12.3 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 1600
|
7.71 USD |
|
13 years ago
Apr 21, 2011
|
Sell 7.73 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 1000
|
7.73 USD |
|
13 years ago
Apr 21, 2011
|
Sell 13.4 K
USD
|
Ichikawa David G
Senior VP, Bus. Dev.
|
- 1728
|
7.75 USD |
|
13 years ago
Feb 28, 2011
|
Sell 12.5 K
USD
|
Cleveland Paul B
Director
|
- 1388
|
9 USD |
|
13 years ago
Feb 28, 2011
|
Sell 22.5 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 2500
|
9 USD |
|
13 years ago
Mar 01, 2011
|
Sell 330
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 40
|
8.24 USD |
|
13 years ago
Mar 01, 2011
|
Sell 2.97 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 360
|
8.25 USD |
|
13 years ago
Mar 01, 2011
|
Sell 5.78 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 700
|
8.26 USD |
|
13 years ago
Mar 01, 2011
|
Sell 8.3 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1000
|
8.3 USD |
|
13 years ago
Mar 01, 2011
|
Sell 1.67 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 200
|
8.33 USD |
|
13 years ago
Mar 01, 2011
|
Sell 1.67 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 200
|
8.335 USD |
|
13 years ago
Feb 01, 2011
|
Sell 2.39 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 300
|
7.96 USD |
|
13 years ago
Feb 01, 2011
|
Sell 15.1 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1900
|
7.97 USD |
|
13 years ago
Feb 01, 2011
|
Sell 2.39 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 300
|
7.98 USD |
|
14 years ago
Jan 03, 2011
|
Sell 17 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 2500
|
6.8002 USD |
|
14 years ago
Dec 22, 2010
|
Sell 154 K
USD
|
Cleveland Paul B
Director
|
- 22037
|
7 USD |
|
14 years ago
Dec 22, 2010
|
Sell 70 K
USD
|
Cleveland Paul B
Director
|
- 10000
|
7 USD |
|
14 years ago
Dec 20, 2010
|
Sell 79.1 K
USD
|
Cleveland Paul B
Director
|
- 11297
|
7 USD |
|
14 years ago
Dec 08, 2010
|
Sell 15 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 2500
|
6 USD |
|
14 years ago
Aug 30, 2010
|
Bought
30 K USD
|
LANPHIER EDWARD O II
President & CEO
|
+ 10000
|
3.005 USD |
|
14 years ago
Aug 30, 2010
|
Bought
27 K USD
|
Wolff Henry Ward
Exec VP & CFO
|
+ 9000
|
3 USD |
|
14 years ago
May 03, 2010
|
Sell 43.5
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 7
|
6.21 USD |
|
14 years ago
May 03, 2010
|
Sell 1.25 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 200
|
6.23 USD |
|
14 years ago
May 03, 2010
|
Sell 1.25 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 200
|
6.24 USD |
|
14 years ago
May 03, 2010
|
Sell 1.88 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 300
|
6.25 USD |
|
14 years ago
May 03, 2010
|
Sell 1.88 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 300
|
6.28 USD |
|
14 years ago
May 03, 2010
|
Sell 9.39 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1493
|
6.29 USD |
|
14 years ago
Apr 14, 2010
|
Sell 3.06 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 500
|
6.12 USD |
|
14 years ago
Apr 14, 2010
|
Sell 6.14 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1000
|
6.14 USD |
|
14 years ago
Apr 14, 2010
|
Sell 6.17 K
USD
|
Gregory Philip D
CSO & Vice President, Research
|
- 1000
|
6.17 USD |
|
17 years ago
Nov 15, 2007
|
Sell 201 K
USD
|
Mento Steven J
Director
|
- 13600
|
14.75 USD |
|
17 years ago
Nov 15, 2007
|
Sell 20.7 K
USD
|
Mento Steven J
Director
|
- 1400
|
14.76 USD |
|
16 years ago
Sep 02, 2008
|
Sell 10.1 K
USD
|
Gregory Philip D
Vice President, Research
|
- 1000
|
10.12 USD |
|
16 years ago
Aug 15, 2008
|
Sell 3.18 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 300
|
10.59 USD |
|
16 years ago
Aug 15, 2008
|
Sell 26.5 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 2500
|
10.595 USD |
|
16 years ago
Aug 15, 2008
|
Sell 165 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 15563
|
10.6 USD |
|
16 years ago
Aug 15, 2008
|
Sell 17 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 1600
|
10.61 USD |
|
16 years ago
Aug 15, 2008
|
Sell 20.2 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 1900
|
10.62 USD |
|
16 years ago
Aug 15, 2008
|
Sell 2.52 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 237
|
10.63 USD |
|
16 years ago
Aug 15, 2008
|
Sell 3.19 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 300
|
10.64 USD |
|
16 years ago
Aug 15, 2008
|
Sell 24.5 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 2300
|
10.65 USD |
|
16 years ago
Aug 15, 2008
|
Sell 3.2 K
USD
|
LANPHIER EDWARD O II
Pres & Chief Ex Officer
|
- 300
|
10.66 USD |
|
16 years ago
Aug 15, 2008
|
Sell 3.18 K
USD
|
Gregory Philip D
Vice President, Research
|
- 300
|
10.59 USD |
|
16 years ago
Aug 15, 2008
|
Sell 59.4 K
USD
|
Gregory Philip D
Vice President, Research
|
- 5600
|
10.6 USD |
|
16 years ago
Aug 15, 2008
|
Sell 15.9 K
USD
|
Gregory Philip D
Vice President, Research
|
- 1500
|
10.61 USD |
|
16 years ago
Aug 15, 2008
|
Sell 2.12 K
USD
|
Gregory Philip D
Vice President, Research
|
- 200
|
10.62 USD |
|
16 years ago
Aug 15, 2008
|
Sell 1.06 K
USD
|
Gregory Philip D
Vice President, Research
|
- 100
|
10.63 USD |
|
16 years ago
Aug 15, 2008
|
Sell 2.13 K
USD
|
Gregory Philip D
Vice President, Research
|
- 200
|
10.64 USD |
|
16 years ago
Aug 15, 2008
|
Sell 1.6 K
USD
|
Gregory Philip D
Vice President, Research
|
- 150
|
10.65 USD |
|
16 years ago
Aug 15, 2008
|
Sell 1.07 K
USD
|
Gregory Philip D
Vice President, Research
|
- 100
|
10.66 USD |
|
16 years ago
Aug 15, 2008
|
Sell 4.8 K
USD
|
Gregory Philip D
Vice President, Research
|
- 450
|
10.67 USD |
|
16 years ago
Aug 15, 2008
|
Sell 6.41 K
USD
|
Gregory Philip D
Vice President, Research
|
- 600
|
10.68 USD |
|
16 years ago
Aug 15, 2008
|
Sell 4.28 K
USD
|
Gregory Philip D
Vice President, Research
|
- 400
|
10.7 USD |
|
16 years ago
Aug 15, 2008
|
Sell 1.07 K
USD
|
Gregory Philip D
Vice President, Research
|
- 100
|
10.73 USD |
|
16 years ago
Aug 15, 2008
|
Sell 1.07 K
USD
|
Gregory Philip D
Vice President, Research
|
- 100
|
10.74 USD |
|
16 years ago
Aug 15, 2008
|
Sell 1.08 K
USD
|
Gregory Philip D
Vice President, Research
|
- 100
|
10.75 USD |
|
16 years ago
Aug 15, 2008
|
Sell 1.08 K
USD
|
Gregory Philip D
Vice President, Research
|
- 100
|
10.76 USD |
|
16 years ago
Aug 01, 2008
|
Sell 1.08 K
USD
|
Gregory Philip D
Vice President, Research
|
- 100
|
10.8 USD |
|
16 years ago
Aug 01, 2008
|
Sell 9.76 K
USD
|
Gregory Philip D
Vice President, Research
|
- 900
|
10.85 USD |
|
16 years ago
Jul 31, 2008
|
Sell 62.8 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 5700
|
11.02 USD |
|
16 years ago
Jul 29, 2008
|
Sell 33.9 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 3000
|
11.29 USD |
|
16 years ago
Jul 29, 2008
|
Sell 11.3 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1000
|
11.28 USD |
|
16 years ago
Jul 29, 2008
|
Sell 24.8 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 2200
|
11.28 USD |
|
16 years ago
Jul 29, 2008
|
Sell 18 K
USD
|
LARSON JOHN WILLIAM
Director
|
- 1600
|
11.22 USD |
7. News
Levi & Korsinsky Announces an Investigation on Behalf of Sangamo Therapeutics, Inc. (SGMO) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. ("Sangamo Therapeutics, Inc.") (NASDAQ:SGMO) concerning possible violations of federal securities laws. Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3.
accesswire.com
- 1 week ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Investors to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / January 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sangamo Therapeutics, Inc. ("Sangamo" or "the Company") (NASDAQ:SGMO). Investors who purchased Sangamo securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SGMO.
accesswire.com
- 1 week ago
Sangamo Therapeutics, Inc. (SGMO) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. ("Sangamo Therapeutics, Inc.") (NASDAQ:SGMO) concerning possible violations of federal securities laws. Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3.
accesswire.com
- 1 week ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sangamo Therapeutics, Inc. - SGMO
NEW YORK CITY, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sangamo Therapeutics, Inc. ("Sangamo" or the "Company") (NASDAQ:SGMO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
accesswire.com
- 1 week ago
SGMO ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Sangamo Therapeutics, Inc. investment
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. ("Sangamo Therapeutics, Inc.") (NASDAQ:SGMO) concerning possible violations of federal securities laws. Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3.
accesswire.com
- 1 week ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sangamo Therapeutics, Inc. (SGMO) And Encourages Stockholders to Connect
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sangamo Therapeutics, Inc. ("Sangamo" or "the Company") (NASDAQ:SGMO). Investors who purchased Sangamo securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SGMO.
accesswire.com
- 1 week ago
SGMO ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Sangamo Therapeutics, Inc. Shareholders Who Lost Money
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. ("Sangamo Therapeutics, Inc.") (NASDAQ:SGMO) concerning possible violations of federal securities laws. Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3.
accesswire.com
- 1 week ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sangamo Therapeutics, Inc. - SGMO
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sangamo Therapeutics, Inc. ("Sangamo" or the "Company") (NASDAQ: SGMO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
accesswire.com
- 2 weeks ago
Investors who lost money on Sangamo Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - SGMO
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. ("Sangamo Therapeutics, Inc.") (NASDAQ:SGMO) concerning possible violations of federal securities laws. Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3.
accesswire.com
- 2 weeks ago
Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / January 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sangamo Therapeutics, Inc. ("Sangamo" or "the Company") (NASDAQ:SGMO). Investors who purchased Sangamo securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SGMO.
accesswire.com
- 2 weeks ago
Sangamo Therapeutics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - SGMO
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. ("Sangamo Therapeutics, Inc.") (NASDAQ:SGMO) concerning possible violations of federal securities laws. Sangamo announced on December 30, 2024, that Pfizer, with whom the Company was co-developing hemophilia A gene therapy candidate giroctocogene fitelparvovec, would be returning after the development and commercialization rights to giroctocogene fitelparvovec after deciding not to pursue commercialization of the asset, which is in phase 3.
accesswire.com
- 2 weeks ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sangamo Therapeutics, Inc. - SGMO
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sangamo Therapeutics, Inc. ("Sangamo" or the "Company") (NASDAQ:SGMO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
accesswire.com
- 2 weeks ago
8. Profile
Summary
Sangamo Therapeutics, Inc. SGMO
COUNTRY
US
INDUSTRY
Biotechnology
MARKET CAP
$ 227 M
Dividend Yield
0.00%
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.
Contact
501 Canal Blvd, Brisbane California, CALIFORNIA, 94005
https://www.sangamo.com
IPO
Date
April 6, 2000
Employees
405
Officers
Mr. Scott B. Willoughby
Senior Vice President, General Counsel & Corporate Secretary
Ms. Louise Wilkie
Vice President of Investor Relations & Corporate Communications
Mr. Gregory Davis Ph.D.
Head of Research & Technology
Dr. Nathalie Dubois-Stringfellow Ph.D.
Senior Vice President & Chief Development Officer
Mr. David Ojala
Scientist II - Discovery & Translational Research
Mr. Phillip Ramsey
Head of Technical Operations
Ms. Prathyusha Duraibabu CPA, M.B.A.
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Chief Executive Officer, President & Director
Ms. Stephanie J. Seiler CLP
Head of Business Development & Alliance Management
Ms. Aron Feingold
Head of Corporate Communications & Investor Relations Officer